nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—PTGS2—type 2 diabetes mellitus	0.38	1	CbGaD
Clodronate—SLC25A4—peripheral nervous system—type 2 diabetes mellitus	0.0152	0.126	CbGeAlD
Clodronate—SLC25A6—islet of Langerhans—type 2 diabetes mellitus	0.00704	0.0583	CbGeAlD
Clodronate—SLC25A5—islet of Langerhans—type 2 diabetes mellitus	0.00613	0.0507	CbGeAlD
Clodronate—SLC25A6—cardiovascular system—type 2 diabetes mellitus	0.00509	0.0422	CbGeAlD
Clodronate—SLC25A6—kidney—type 2 diabetes mellitus	0.00498	0.0412	CbGeAlD
Clodronate—SLC25A6—pancreas—type 2 diabetes mellitus	0.00495	0.041	CbGeAlD
Clodronate—SLC25A5—nephron tubule—type 2 diabetes mellitus	0.00493	0.0408	CbGeAlD
Clodronate—SLC25A4—retina—type 2 diabetes mellitus	0.00491	0.0406	CbGeAlD
Clodronate—SLC25A6—adipose tissue—type 2 diabetes mellitus	0.00449	0.0372	CbGeAlD
Clodronate—SLC25A5—cardiovascular system—type 2 diabetes mellitus	0.00443	0.0367	CbGeAlD
Clodronate—PTGS2—leg—type 2 diabetes mellitus	0.00439	0.0363	CbGeAlD
Clodronate—SLC25A5—kidney—type 2 diabetes mellitus	0.00434	0.0359	CbGeAlD
Clodronate—SLC25A5—pancreas—type 2 diabetes mellitus	0.00431	0.0356	CbGeAlD
Clodronate—SLC25A5—cortex of kidney—type 2 diabetes mellitus	0.00422	0.0349	CbGeAlD
Clodronate—SLC25A4—cardiovascular system—type 2 diabetes mellitus	0.00415	0.0344	CbGeAlD
Clodronate—SLC25A4—kidney—type 2 diabetes mellitus	0.00406	0.0336	CbGeAlD
Clodronate—SLC25A4—cortex of kidney—type 2 diabetes mellitus	0.00396	0.0327	CbGeAlD
Clodronate—PTGS2—hindlimb—type 2 diabetes mellitus	0.00392	0.0324	CbGeAlD
Clodronate—SLC25A5—adipose tissue—type 2 diabetes mellitus	0.00391	0.0323	CbGeAlD
Clodronate—SLC25A4—adipose tissue—type 2 diabetes mellitus	0.00366	0.0303	CbGeAlD
Clodronate—SLC25A6—liver—type 2 diabetes mellitus	0.00315	0.0261	CbGeAlD
Clodronate—SLC25A5—liver—type 2 diabetes mellitus	0.00274	0.0227	CbGeAlD
Clodronate—SLC25A4—liver—type 2 diabetes mellitus	0.00257	0.0213	CbGeAlD
Clodronate—PTGS2—artery—type 2 diabetes mellitus	0.0024	0.0199	CbGeAlD
Clodronate—PTGS2—endothelium—type 2 diabetes mellitus	0.00203	0.0168	CbGeAlD
Clodronate—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.00115	0.00955	CbGeAlD
Clodronate—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000834	0.00691	CbGeAlD
Clodronate—PTGS2—kidney—type 2 diabetes mellitus	0.000816	0.00676	CbGeAlD
Clodronate—PTGS2—pancreas—type 2 diabetes mellitus	0.000811	0.00671	CbGeAlD
Clodronate—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000736	0.00609	CbGeAlD
Clodronate—Pharyngitis—Gliclazide—type 2 diabetes mellitus	0.000553	0.00211	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Sitagliptin—type 2 diabetes mellitus	0.000552	0.00211	CcSEcCtD
Clodronate—Urticaria—Repaglinide—type 2 diabetes mellitus	0.00055	0.0021	CcSEcCtD
Clodronate—Dysphagia—Irbesartan—type 2 diabetes mellitus	0.00055	0.0021	CcSEcCtD
Clodronate—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000549	0.0021	CcSEcCtD
Clodronate—Abdominal pain—Repaglinide—type 2 diabetes mellitus	0.000547	0.00209	CcSEcCtD
Clodronate—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.000547	0.00209	CcSEcCtD
Clodronate—Anorexia—Glipizide—type 2 diabetes mellitus	0.000546	0.00209	CcSEcCtD
Clodronate—Infection—Pioglitazone—type 2 diabetes mellitus	0.000545	0.00208	CcSEcCtD
Clodronate—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000544	0.00208	CcSEcCtD
Clodronate—Rash—Tolazamide—type 2 diabetes mellitus	0.000544	0.00208	CcSEcCtD
Clodronate—Renal impairment—Ramipril—type 2 diabetes mellitus	0.000539	0.00206	CcSEcCtD
Clodronate—Rash—Linagliptin—type 2 diabetes mellitus	0.000539	0.00206	CcSEcCtD
Clodronate—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000538	0.00206	CcSEcCtD
Clodronate—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.000533	0.00204	CcSEcCtD
Clodronate—Infection—Sitagliptin—type 2 diabetes mellitus	0.000529	0.00202	CcSEcCtD
Clodronate—Vomiting—Acarbose—type 2 diabetes mellitus	0.000527	0.00201	CcSEcCtD
Clodronate—Cardiac failure—Ramipril—type 2 diabetes mellitus	0.000526	0.00201	CcSEcCtD
Clodronate—Rash—Acarbose—type 2 diabetes mellitus	0.000523	0.002	CcSEcCtD
Clodronate—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000523	0.002	CcSEcCtD
Clodronate—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.00052	0.00199	CcSEcCtD
Clodronate—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.000518	0.00198	CcSEcCtD
Clodronate—PTGS2—liver—type 2 diabetes mellitus	0.000516	0.00427	CbGeAlD
Clodronate—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000513	0.00196	CcSEcCtD
Clodronate—Nausea—Tolazamide—type 2 diabetes mellitus	0.000513	0.00196	CcSEcCtD
Clodronate—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.000511	0.00195	CcSEcCtD
Clodronate—Anorexia—Glimepiride—type 2 diabetes mellitus	0.00051	0.00195	CcSEcCtD
Clodronate—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000509	0.00194	CcSEcCtD
Clodronate—Pharyngitis—Valsartan—type 2 diabetes mellitus	0.000508	0.00194	CcSEcCtD
Clodronate—Urinary tract disorder—Valsartan—type 2 diabetes mellitus	0.000506	0.00193	CcSEcCtD
Clodronate—Rash—Nateglinide—type 2 diabetes mellitus	0.000504	0.00193	CcSEcCtD
Clodronate—Dyspepsia—Glipizide—type 2 diabetes mellitus	0.000504	0.00193	CcSEcCtD
Clodronate—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000504	0.00192	CcSEcCtD
Clodronate—Connective tissue disorder—Valsartan—type 2 diabetes mellitus	0.000503	0.00192	CcSEcCtD
Clodronate—Pharyngitis—Orlistat—type 2 diabetes mellitus	0.000502	0.00192	CcSEcCtD
Clodronate—Urethral disorder—Valsartan—type 2 diabetes mellitus	0.000502	0.00192	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.0005	0.00191	CcSEcCtD
Clodronate—Urinary tract disorder—Orlistat—type 2 diabetes mellitus	0.0005	0.00191	CcSEcCtD
Clodronate—Anaemia—Glyburide—type 2 diabetes mellitus	0.000499	0.00191	CcSEcCtD
Clodronate—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.000498	0.0019	CcSEcCtD
Clodronate—Urethral disorder—Orlistat—type 2 diabetes mellitus	0.000496	0.00189	CcSEcCtD
Clodronate—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000495	0.00189	CcSEcCtD
Clodronate—Angioedema—Glyburide—type 2 diabetes mellitus	0.000494	0.00189	CcSEcCtD
Clodronate—Pneumonia—Irbesartan—type 2 diabetes mellitus	0.000493	0.00188	CcSEcCtD
Clodronate—Nausea—Acarbose—type 2 diabetes mellitus	0.000493	0.00188	CcSEcCtD
Clodronate—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00049	0.00187	CcSEcCtD
Clodronate—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.000489	0.00187	CcSEcCtD
Clodronate—Renal failure—Irbesartan—type 2 diabetes mellitus	0.000482	0.00184	CcSEcCtD
Clodronate—Blood creatinine increased—Ramipril—type 2 diabetes mellitus	0.000481	0.00184	CcSEcCtD
Clodronate—Infection—Bromocriptine—type 2 diabetes mellitus	0.000479	0.00183	CcSEcCtD
Clodronate—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000477	0.00182	CcSEcCtD
Clodronate—Nausea—Nateglinide—type 2 diabetes mellitus	0.000475	0.00181	CcSEcCtD
Clodronate—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000474	0.00181	CcSEcCtD
Clodronate—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000474	0.00181	CcSEcCtD
Clodronate—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000471	0.0018	CcSEcCtD
Clodronate—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000469	0.00179	CcSEcCtD
Clodronate—Abdominal pain upper—Ramipril—type 2 diabetes mellitus	0.000469	0.00179	CcSEcCtD
Clodronate—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000468	0.00179	CcSEcCtD
Clodronate—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000465	0.00177	CcSEcCtD
Clodronate—Pneumonia—Losartan—type 2 diabetes mellitus	0.000464	0.00177	CcSEcCtD
Clodronate—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000463	0.00177	CcSEcCtD
Clodronate—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000463	0.00177	CcSEcCtD
Clodronate—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000462	0.00176	CcSEcCtD
Clodronate—Mediastinal disorder—Valsartan—type 2 diabetes mellitus	0.000461	0.00176	CcSEcCtD
Clodronate—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.00046	0.00176	CcSEcCtD
Clodronate—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.00046	0.00176	CcSEcCtD
Clodronate—Connective tissue disorder—Metformin—type 2 diabetes mellitus	0.000458	0.00175	CcSEcCtD
Clodronate—Mediastinal disorder—Orlistat—type 2 diabetes mellitus	0.000456	0.00174	CcSEcCtD
Clodronate—Urticaria—Glipizide—type 2 diabetes mellitus	0.000455	0.00174	CcSEcCtD
Clodronate—Renal failure—Losartan—type 2 diabetes mellitus	0.000453	0.00173	CcSEcCtD
Clodronate—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000453	0.00173	CcSEcCtD
Clodronate—Anaemia—Gliclazide—type 2 diabetes mellitus	0.000448	0.00171	CcSEcCtD
Clodronate—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000448	0.00171	CcSEcCtD
Clodronate—Dysphagia—Ramipril—type 2 diabetes mellitus	0.000444	0.00169	CcSEcCtD
Clodronate—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000443	0.00169	CcSEcCtD
Clodronate—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00044	0.00168	CcSEcCtD
Clodronate—Pharyngitis—Irbesartan—type 2 diabetes mellitus	0.000437	0.00167	CcSEcCtD
Clodronate—Rash—Repaglinide—type 2 diabetes mellitus	0.000437	0.00167	CcSEcCtD
Clodronate—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.000436	0.00167	CcSEcCtD
Clodronate—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000436	0.00167	CcSEcCtD
Clodronate—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000436	0.00167	CcSEcCtD
Clodronate—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.000434	0.00166	CcSEcCtD
Clodronate—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.000432	0.00165	CcSEcCtD
Clodronate—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000431	0.00165	CcSEcCtD
Clodronate—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.00043	0.00164	CcSEcCtD
Clodronate—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000425	0.00162	CcSEcCtD
Clodronate—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000425	0.00162	CcSEcCtD
Clodronate—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000423	0.00162	CcSEcCtD
Clodronate—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000423	0.00161	CcSEcCtD
Clodronate—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000421	0.00161	CcSEcCtD
Clodronate—Anorexia—Glyburide—type 2 diabetes mellitus	0.00042	0.00161	CcSEcCtD
Clodronate—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.00042	0.0016	CcSEcCtD
Clodronate—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000419	0.0016	CcSEcCtD
Clodronate—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000416	0.00159	CcSEcCtD
Clodronate—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000413	0.00158	CcSEcCtD
Clodronate—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000412	0.00157	CcSEcCtD
Clodronate—Nausea—Repaglinide—type 2 diabetes mellitus	0.000411	0.00157	CcSEcCtD
Clodronate—Pharyngitis—Losartan—type 2 diabetes mellitus	0.000411	0.00157	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.00041	0.00157	CcSEcCtD
Clodronate—Angioedema—Valsartan—type 2 diabetes mellitus	0.000407	0.00156	CcSEcCtD
Clodronate—Pruritus—Glipizide—type 2 diabetes mellitus	0.000405	0.00155	CcSEcCtD
Clodronate—Angioedema—Orlistat—type 2 diabetes mellitus	0.000402	0.00154	CcSEcCtD
Clodronate—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000396	0.00151	CcSEcCtD
Clodronate—Infection—Gliclazide—type 2 diabetes mellitus	0.000393	0.0015	CcSEcCtD
Clodronate—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000393	0.0015	CcSEcCtD
Clodronate—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000392	0.0015	CcSEcCtD
Clodronate—Renal failure—Ramipril—type 2 diabetes mellitus	0.000389	0.00148	CcSEcCtD
Clodronate—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000389	0.00148	CcSEcCtD
Clodronate—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000388	0.00148	CcSEcCtD
Clodronate—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000385	0.00147	CcSEcCtD
Clodronate—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000383	0.00146	CcSEcCtD
Clodronate—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000383	0.00146	CcSEcCtD
Clodronate—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000381	0.00146	CcSEcCtD
Clodronate—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000381	0.00145	CcSEcCtD
Clodronate—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000378	0.00144	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000377	0.00144	CcSEcCtD
Clodronate—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000375	0.00143	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000372	0.00142	CcSEcCtD
Clodronate—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000366	0.0014	CcSEcCtD
Clodronate—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000365	0.00139	CcSEcCtD
Clodronate—Vomiting—Glipizide—type 2 diabetes mellitus	0.000364	0.00139	CcSEcCtD
Clodronate—Infection—Valsartan—type 2 diabetes mellitus	0.000361	0.00138	CcSEcCtD
Clodronate—Rash—Glipizide—type 2 diabetes mellitus	0.000361	0.00138	CcSEcCtD
Clodronate—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000361	0.00138	CcSEcCtD
Clodronate—Infection—Orlistat—type 2 diabetes mellitus	0.000357	0.00136	CcSEcCtD
Clodronate—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000354	0.00135	CcSEcCtD
Clodronate—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000353	0.00135	CcSEcCtD
Clodronate—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000353	0.00135	CcSEcCtD
Clodronate—Urticaria—Glyburide—type 2 diabetes mellitus	0.00035	0.00134	CcSEcCtD
Clodronate—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00035	0.00134	CcSEcCtD
Clodronate—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000349	0.00133	CcSEcCtD
Clodronate—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000349	0.00133	CcSEcCtD
Clodronate—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000349	0.00133	CcSEcCtD
Clodronate—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000348	0.00133	CcSEcCtD
Clodronate—Anorexia—Valsartan—type 2 diabetes mellitus	0.000347	0.00132	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000343	0.00131	CcSEcCtD
Clodronate—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000342	0.00131	CcSEcCtD
Clodronate—Nausea—Glipizide—type 2 diabetes mellitus	0.00034	0.0013	CcSEcCtD
Clodronate—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00034	0.0013	CcSEcCtD
Clodronate—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000339	0.00129	CcSEcCtD
Clodronate—Rash—Glimepiride—type 2 diabetes mellitus	0.000337	0.00129	CcSEcCtD
Clodronate—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000337	0.00129	CcSEcCtD
Clodronate—Rash—Sitagliptin—type 2 diabetes mellitus	0.000336	0.00128	CcSEcCtD
Clodronate—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000336	0.00128	CcSEcCtD
Clodronate—Anaemia—Losartan—type 2 diabetes mellitus	0.000333	0.00127	CcSEcCtD
Clodronate—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00033	0.00126	CcSEcCtD
Clodronate—Angioedema—Losartan—type 2 diabetes mellitus	0.000329	0.00126	CcSEcCtD
Clodronate—Infection—Metformin—type 2 diabetes mellitus	0.000329	0.00126	CcSEcCtD
Clodronate—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000324	0.00124	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000324	0.00124	CcSEcCtD
Clodronate—Skin disorder—Metformin—type 2 diabetes mellitus	0.000322	0.00123	CcSEcCtD
Clodronate—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00032	0.00122	CcSEcCtD
Clodronate—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.00032	0.00122	CcSEcCtD
Clodronate—Nausea—Glimepiride—type 2 diabetes mellitus	0.000318	0.00121	CcSEcCtD
Clodronate—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000317	0.00121	CcSEcCtD
Clodronate—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000316	0.00121	CcSEcCtD
Clodronate—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000316	0.00121	CcSEcCtD
Clodronate—Anorexia—Metformin—type 2 diabetes mellitus	0.000316	0.00121	CcSEcCtD
Clodronate—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000314	0.0012	CcSEcCtD
Clodronate—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000314	0.0012	CcSEcCtD
Clodronate—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000313	0.0012	CcSEcCtD
Clodronate—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000312	0.00119	CcSEcCtD
Clodronate—Pruritus—Glyburide—type 2 diabetes mellitus	0.000312	0.00119	CcSEcCtD
Clodronate—Infection—Irbesartan—type 2 diabetes mellitus	0.000311	0.00119	CcSEcCtD
Clodronate—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.00031	0.00119	CcSEcCtD
Clodronate—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000307	0.00117	CcSEcCtD
Clodronate—Rash—Bromocriptine—type 2 diabetes mellitus	0.000304	0.00116	CcSEcCtD
Clodronate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000304	0.00116	CcSEcCtD
Clodronate—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000304	0.00116	CcSEcCtD
Clodronate—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000302	0.00115	CcSEcCtD
Clodronate—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000298	0.00114	CcSEcCtD
Clodronate—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000295	0.00113	CcSEcCtD
Clodronate—Infection—Losartan—type 2 diabetes mellitus	0.000292	0.00112	CcSEcCtD
Clodronate—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000292	0.00111	CcSEcCtD
Clodronate—Urticaria—Valsartan—type 2 diabetes mellitus	0.000289	0.0011	CcSEcCtD
Clodronate—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000288	0.0011	CcSEcCtD
Clodronate—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000288	0.0011	CcSEcCtD
Clodronate—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000286	0.00109	CcSEcCtD
Clodronate—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000286	0.00109	CcSEcCtD
Clodronate—Urticaria—Orlistat—type 2 diabetes mellitus	0.000286	0.00109	CcSEcCtD
Clodronate—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000284	0.00109	CcSEcCtD
Clodronate—Angioedema—Ramipril—type 2 diabetes mellitus	0.000282	0.00108	CcSEcCtD
Clodronate—Anorexia—Losartan—type 2 diabetes mellitus	0.00028	0.00107	CcSEcCtD
Clodronate—Vomiting—Glyburide—type 2 diabetes mellitus	0.00028	0.00107	CcSEcCtD
Clodronate—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00028	0.00107	CcSEcCtD
Clodronate—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000279	0.00106	CcSEcCtD
Clodronate—Rash—Glyburide—type 2 diabetes mellitus	0.000278	0.00106	CcSEcCtD
Clodronate—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000278	0.00106	CcSEcCtD
Clodronate—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000275	0.00105	CcSEcCtD
Clodronate—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000272	0.00104	CcSEcCtD
Clodronate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000271	0.00103	CcSEcCtD
Clodronate—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.00027	0.00103	CcSEcCtD
Clodronate—Urticaria—Metformin—type 2 diabetes mellitus	0.000263	0.00101	CcSEcCtD
Clodronate—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000262	0.001	CcSEcCtD
Clodronate—Nausea—Glyburide—type 2 diabetes mellitus	0.000262	0.001	CcSEcCtD
Clodronate—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000262	0.001	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000261	0.000998	CcSEcCtD
Clodronate—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000259	0.000989	CcSEcCtD
Clodronate—Pruritus—Valsartan—type 2 diabetes mellitus	0.000257	0.000983	CcSEcCtD
Clodronate—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000256	0.000977	CcSEcCtD
Clodronate—Pruritus—Orlistat—type 2 diabetes mellitus	0.000254	0.000971	CcSEcCtD
Clodronate—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000252	0.000961	CcSEcCtD
Clodronate—Rash—Gliclazide—type 2 diabetes mellitus	0.00025	0.000953	CcSEcCtD
Clodronate—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000249	0.000952	CcSEcCtD
Clodronate—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000249	0.000951	CcSEcCtD
Clodronate—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000248	0.000948	CcSEcCtD
Clodronate—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000247	0.000944	CcSEcCtD
Clodronate—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000246	0.000939	CcSEcCtD
Clodronate—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000245	0.000936	CcSEcCtD
Clodronate—Anorexia—Ramipril—type 2 diabetes mellitus	0.00024	0.000918	CcSEcCtD
Clodronate—Nausea—Gliclazide—type 2 diabetes mellitus	0.000235	0.000898	CcSEcCtD
Clodronate—Pruritus—Metformin—type 2 diabetes mellitus	0.000234	0.000895	CcSEcCtD
Clodronate—Urticaria—Losartan—type 2 diabetes mellitus	0.000234	0.000893	CcSEcCtD
Clodronate—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000233	0.000888	CcSEcCtD
Clodronate—Vomiting—Valsartan—type 2 diabetes mellitus	0.000231	0.000883	CcSEcCtD
Clodronate—Rash—Valsartan—type 2 diabetes mellitus	0.000229	0.000876	CcSEcCtD
Clodronate—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000229	0.000875	CcSEcCtD
Clodronate—Vomiting—Orlistat—type 2 diabetes mellitus	0.000229	0.000873	CcSEcCtD
Clodronate—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000227	0.000866	CcSEcCtD
Clodronate—Rash—Orlistat—type 2 diabetes mellitus	0.000227	0.000866	CcSEcCtD
Clodronate—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000226	0.000865	CcSEcCtD
Clodronate—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000225	0.000859	CcSEcCtD
Clodronate—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000222	0.000848	CcSEcCtD
Clodronate—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000221	0.000845	CcSEcCtD
Clodronate—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000219	0.000837	CcSEcCtD
Clodronate—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000218	0.000832	CcSEcCtD
Clodronate—Nausea—Valsartan—type 2 diabetes mellitus	0.000216	0.000825	CcSEcCtD
Clodronate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000214	0.000817	CcSEcCtD
Clodronate—Nausea—Orlistat—type 2 diabetes mellitus	0.000213	0.000815	CcSEcCtD
Clodronate—Vomiting—Metformin—type 2 diabetes mellitus	0.000211	0.000804	CcSEcCtD
Clodronate—Rash—Metformin—type 2 diabetes mellitus	0.000209	0.000798	CcSEcCtD
Clodronate—Dermatitis—Metformin—type 2 diabetes mellitus	0.000209	0.000797	CcSEcCtD
Clodronate—Pruritus—Losartan—type 2 diabetes mellitus	0.000208	0.000795	CcSEcCtD
Clodronate—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000201	0.000769	CcSEcCtD
Clodronate—Urticaria—Ramipril—type 2 diabetes mellitus	0.0002	0.000765	CcSEcCtD
Clodronate—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000199	0.000762	CcSEcCtD
Clodronate—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000199	0.000759	CcSEcCtD
Clodronate—Rash—Irbesartan—type 2 diabetes mellitus	0.000197	0.000753	CcSEcCtD
Clodronate—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000197	0.000752	CcSEcCtD
Clodronate—Nausea—Metformin—type 2 diabetes mellitus	0.000197	0.000751	CcSEcCtD
Clodronate—Vomiting—Losartan—type 2 diabetes mellitus	0.000187	0.000714	CcSEcCtD
Clodronate—Nausea—Irbesartan—type 2 diabetes mellitus	0.000186	0.000709	CcSEcCtD
Clodronate—Rash—Losartan—type 2 diabetes mellitus	0.000185	0.000708	CcSEcCtD
Clodronate—Dermatitis—Losartan—type 2 diabetes mellitus	0.000185	0.000708	CcSEcCtD
Clodronate—Pruritus—Ramipril—type 2 diabetes mellitus	0.000178	0.000682	CcSEcCtD
Clodronate—Nausea—Losartan—type 2 diabetes mellitus	0.000175	0.000667	CcSEcCtD
Clodronate—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000173	0.000659	CcSEcCtD
Clodronate—Vomiting—Ramipril—type 2 diabetes mellitus	0.00016	0.000613	CcSEcCtD
Clodronate—Rash—Ramipril—type 2 diabetes mellitus	0.000159	0.000607	CcSEcCtD
Clodronate—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000159	0.000607	CcSEcCtD
Clodronate—Nausea—Ramipril—type 2 diabetes mellitus	0.00015	0.000572	CcSEcCtD
Clodronate—SLC25A4—Metabolism—CAT—type 2 diabetes mellitus	5.99e-05	0.000253	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—CALM1—type 2 diabetes mellitus	5.99e-05	0.000252	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	5.98e-05	0.000252	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MTHFR—type 2 diabetes mellitus	5.97e-05	0.000252	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—APOE—type 2 diabetes mellitus	5.97e-05	0.000251	CbGpPWpGaD
Clodronate—PTGS2—Disease—VPS26A—type 2 diabetes mellitus	5.96e-05	0.000251	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—APOA1—type 2 diabetes mellitus	5.9e-05	0.000249	CbGpPWpGaD
Clodronate—SLC25A6—Disease—AKT2—type 2 diabetes mellitus	5.88e-05	0.000248	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PTGS2—type 2 diabetes mellitus	5.82e-05	0.000245	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—APOB—type 2 diabetes mellitus	5.82e-05	0.000245	CbGpPWpGaD
Clodronate—SLC25A4—Disease—HIF1A—type 2 diabetes mellitus	5.7e-05	0.00024	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IRS2—type 2 diabetes mellitus	5.68e-05	0.000239	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GSTM1—type 2 diabetes mellitus	5.66e-05	0.000239	CbGpPWpGaD
Clodronate—SLC25A6—Disease—SERPINE1—type 2 diabetes mellitus	5.59e-05	0.000236	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CALM1—type 2 diabetes mellitus	5.58e-05	0.000235	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—ALB—type 2 diabetes mellitus	5.58e-05	0.000235	CbGpPWpGaD
Clodronate—SLC25A4—Disease—APOE—type 2 diabetes mellitus	5.56e-05	0.000234	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—LPL—type 2 diabetes mellitus	5.56e-05	0.000234	CbGpPWpGaD
Clodronate—SLC25A4—Disease—APOA1—type 2 diabetes mellitus	5.5e-05	0.000232	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—NFKB1—type 2 diabetes mellitus	5.47e-05	0.000231	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ADCY5—type 2 diabetes mellitus	5.44e-05	0.000229	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GPX1—type 2 diabetes mellitus	5.42e-05	0.000228	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	5.39e-05	0.000227	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PIK3R1—type 2 diabetes mellitus	5.34e-05	0.000225	CbGpPWpGaD
Clodronate—SLC25A6—Disease—NOS3—type 2 diabetes mellitus	5.34e-05	0.000225	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—NOS3—type 2 diabetes mellitus	5.33e-05	0.000225	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PIK3R1—type 2 diabetes mellitus	5.33e-05	0.000225	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CD36—type 2 diabetes mellitus	5.28e-05	0.000222	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PPP2CA—type 2 diabetes mellitus	5.21e-05	0.00022	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PPARG—type 2 diabetes mellitus	5.2e-05	0.000219	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NOS2—type 2 diabetes mellitus	5.18e-05	0.000218	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—INS—type 2 diabetes mellitus	5.1e-05	0.000215	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	5.09e-05	0.000214	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	5.09e-05	0.000214	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—MTHFR—type 2 diabetes mellitus	5e-05	0.000211	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—BHMT—type 2 diabetes mellitus	4.99e-05	0.00021	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IRS1—type 2 diabetes mellitus	4.96e-05	0.000209	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PPARA—type 2 diabetes mellitus	4.91e-05	0.000207	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PTGS2—type 2 diabetes mellitus	4.88e-05	0.000206	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PTGS2—type 2 diabetes mellitus	4.88e-05	0.000206	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—AGT—type 2 diabetes mellitus	4.75e-05	0.0002	CbGpPWpGaD
Clodronate—SLC25A4—Disease—INS—type 2 diabetes mellitus	4.75e-05	0.0002	CbGpPWpGaD
Clodronate—SLC25A5—Disease—SRC—type 2 diabetes mellitus	4.71e-05	0.000199	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—CALM1—type 2 diabetes mellitus	4.67e-05	0.000197	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ALB—type 2 diabetes mellitus	4.67e-05	0.000197	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—APOE—type 2 diabetes mellitus	4.66e-05	0.000196	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CASP3—type 2 diabetes mellitus	4.63e-05	0.000195	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—APOA1—type 2 diabetes mellitus	4.6e-05	0.000194	CbGpPWpGaD
Clodronate—SLC25A4—Disease—AKT2—type 2 diabetes mellitus	4.59e-05	0.000193	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PIK3R1—type 2 diabetes mellitus	4.47e-05	0.000188	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—NOS3—type 2 diabetes mellitus	4.47e-05	0.000188	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—MMP9—type 2 diabetes mellitus	4.37e-05	0.000184	CbGpPWpGaD
Clodronate—SLC25A4—Disease—SERPINE1—type 2 diabetes mellitus	4.36e-05	0.000184	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—AANAT—type 2 diabetes mellitus	4.36e-05	0.000184	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PTGDS—type 2 diabetes mellitus	4.36e-05	0.000184	CbGpPWpGaD
Clodronate—PTGS2—Disease—SLC5A4—type 2 diabetes mellitus	4.35e-05	0.000183	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—TNF—type 2 diabetes mellitus	4.26e-05	0.000179	CbGpPWpGaD
Clodronate—SLC25A5—Disease—TGFB1—type 2 diabetes mellitus	4.21e-05	0.000177	CbGpPWpGaD
Clodronate—PTGS2—Disease—ENPP1—type 2 diabetes mellitus	4.2e-05	0.000177	CbGpPWpGaD
Clodronate—PTGS2—Disease—PPP1R3C—type 2 diabetes mellitus	4.2e-05	0.000177	CbGpPWpGaD
Clodronate—PTGS2—Disease—G6PC—type 2 diabetes mellitus	4.2e-05	0.000177	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PIK3R1—type 2 diabetes mellitus	4.17e-05	0.000176	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NOS3—type 2 diabetes mellitus	4.17e-05	0.000176	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	4.16e-05	0.000175	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	4.15e-05	0.000175	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GPD2—type 2 diabetes mellitus	4.13e-05	0.000174	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CDO1—type 2 diabetes mellitus	4.13e-05	0.000174	CbGpPWpGaD
Clodronate—SLC25A5—Disease—EGFR—type 2 diabetes mellitus	4.13e-05	0.000174	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	4.09e-05	0.000172	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PTGS2—type 2 diabetes mellitus	4.09e-05	0.000172	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PPARG—type 2 diabetes mellitus	4.06e-05	0.000171	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	4.04e-05	0.00017	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	4.02e-05	0.000169	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—INS—type 2 diabetes mellitus	3.98e-05	0.000168	CbGpPWpGaD
Clodronate—SLC25A6—Disease—SRC—type 2 diabetes mellitus	3.95e-05	0.000166	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—AK1—type 2 diabetes mellitus	3.94e-05	0.000166	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	3.9e-05	0.000164	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PTGS2—type 2 diabetes mellitus	3.81e-05	0.000161	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ALB—type 2 diabetes mellitus	3.65e-05	0.000154	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLC5A4—type 2 diabetes mellitus	3.64e-05	0.000153	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MAT1A—type 2 diabetes mellitus	3.64e-05	0.000153	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	3.62e-05	0.000153	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TGFB1—type 2 diabetes mellitus	3.61e-05	0.000152	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	3.57e-05	0.00015	CbGpPWpGaD
Clodronate—PTGS2—Disease—ACACA—type 2 diabetes mellitus	3.57e-05	0.00015	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	3.56e-05	0.00015	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—EGFR—type 2 diabetes mellitus	3.53e-05	0.000149	CbGpPWpGaD
Clodronate—SLC25A6—Disease—TGFB1—type 2 diabetes mellitus	3.53e-05	0.000149	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	3.53e-05	0.000149	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ND1—type 2 diabetes mellitus	3.52e-05	0.000148	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PPP1R3C—type 2 diabetes mellitus	3.52e-05	0.000148	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—G6PC—type 2 diabetes mellitus	3.52e-05	0.000148	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HBA2—type 2 diabetes mellitus	3.52e-05	0.000148	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ENPP1—type 2 diabetes mellitus	3.52e-05	0.000148	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—NOS3—type 2 diabetes mellitus	3.49e-05	0.000147	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3R1—type 2 diabetes mellitus	3.49e-05	0.000147	CbGpPWpGaD
Clodronate—SLC25A6—Disease—EGFR—type 2 diabetes mellitus	3.46e-05	0.000146	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL6—type 2 diabetes mellitus	3.44e-05	0.000145	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GCGR—type 2 diabetes mellitus	3.41e-05	0.000144	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TNF—type 2 diabetes mellitus	3.37e-05	0.000142	CbGpPWpGaD
Clodronate—PTGS2—Disease—SLC5A2—type 2 diabetes mellitus	3.29e-05	0.000139	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	3.28e-05	0.000138	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYTB—type 2 diabetes mellitus	3.22e-05	0.000136	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—OXCT1—type 2 diabetes mellitus	3.22e-05	0.000136	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PTGS2—type 2 diabetes mellitus	3.19e-05	0.000134	CbGpPWpGaD
Clodronate—SLC25A5—Disease—IL6—type 2 diabetes mellitus	3.17e-05	0.000134	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	3.15e-05	0.000133	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SRD5A1—type 2 diabetes mellitus	3.13e-05	0.000132	CbGpPWpGaD
Clodronate—SLC25A4—Disease—SRC—type 2 diabetes mellitus	3.08e-05	0.00013	CbGpPWpGaD
Clodronate—PTGS2—Disease—PCK1—type 2 diabetes mellitus	2.99e-05	0.000126	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—STAR—type 2 diabetes mellitus	2.99e-05	0.000126	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HSD17B3—type 2 diabetes mellitus	2.99e-05	0.000126	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ACACA—type 2 diabetes mellitus	2.99e-05	0.000126	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	2.94e-05	0.000124	CbGpPWpGaD
Clodronate—SLC25A5—Disease—AKT1—type 2 diabetes mellitus	2.93e-05	0.000123	CbGpPWpGaD
Clodronate—PTGS2—Disease—TLE4—type 2 diabetes mellitus	2.91e-05	0.000123	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CBS—type 2 diabetes mellitus	2.87e-05	0.000121	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCC8—type 2 diabetes mellitus	2.87e-05	0.000121	CbGpPWpGaD
Clodronate—PTGS2—Disease—HK1—type 2 diabetes mellitus	2.8e-05	0.000118	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLC5A2—type 2 diabetes mellitus	2.76e-05	0.000116	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—COX2—type 2 diabetes mellitus	2.76e-05	0.000116	CbGpPWpGaD
Clodronate—SLC25A4—Disease—TGFB1—type 2 diabetes mellitus	2.75e-05	0.000116	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	2.74e-05	0.000116	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL6—type 2 diabetes mellitus	2.72e-05	0.000114	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NCOA6—type 2 diabetes mellitus	2.71e-05	0.000114	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	2.71e-05	0.000114	CbGpPWpGaD
Clodronate—PTGS2—Disease—GCKR—type 2 diabetes mellitus	2.71e-05	0.000114	CbGpPWpGaD
Clodronate—SLC25A4—Disease—EGFR—type 2 diabetes mellitus	2.7e-05	0.000114	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	2.67e-05	0.000113	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HSD11B1—type 2 diabetes mellitus	2.66e-05	0.000112	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—UCP2—type 2 diabetes mellitus	2.66e-05	0.000112	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—UCP3—type 2 diabetes mellitus	2.66e-05	0.000112	CbGpPWpGaD
Clodronate—SLC25A6—Disease—IL6—type 2 diabetes mellitus	2.66e-05	0.000112	CbGpPWpGaD
Clodronate—PTGS2—Disease—ALDOB—type 2 diabetes mellitus	2.59e-05	0.000109	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	2.58e-05	0.000109	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PCK1—type 2 diabetes mellitus	2.51e-05	0.000106	CbGpPWpGaD
Clodronate—PTGS2—Disease—SPRY2—type 2 diabetes mellitus	2.47e-05	0.000104	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.47e-05	0.000104	CbGpPWpGaD
Clodronate—SLC25A6—Disease—AKT1—type 2 diabetes mellitus	2.45e-05	0.000103	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	2.45e-05	0.000103	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—AKT1—type 2 diabetes mellitus	2.45e-05	0.000103	CbGpPWpGaD
Clodronate—PTGS2—Disease—RBP4—type 2 diabetes mellitus	2.41e-05	0.000102	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.41e-05	0.000101	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	2.4e-05	0.000101	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HK1—type 2 diabetes mellitus	2.35e-05	9.89e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.34e-05	9.88e-05	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	2.29e-05	9.65e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—KCNJ11—type 2 diabetes mellitus	2.27e-05	9.55e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GCKR—type 2 diabetes mellitus	2.27e-05	9.55e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HSD3B2—type 2 diabetes mellitus	2.27e-05	9.55e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—LPA—type 2 diabetes mellitus	2.27e-05	9.55e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—SLC2A2—type 2 diabetes mellitus	2.25e-05	9.49e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MTR—type 2 diabetes mellitus	2.21e-05	9.29e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.18e-05	9.18e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALDOB—type 2 diabetes mellitus	2.17e-05	9.15e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NAMPT—type 2 diabetes mellitus	2.16e-05	9.11e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—GCK—type 2 diabetes mellitus	2.15e-05	9.06e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—IAPP—type 2 diabetes mellitus	2.14e-05	9e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.11e-05	8.89e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—SLC9A1—type 2 diabetes mellitus	2.1e-05	8.84e-05	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IL6—type 2 diabetes mellitus	2.08e-05	8.75e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.07e-05	8.71e-05	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—AKT1—type 2 diabetes mellitus	2.05e-05	8.66e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.04e-05	8.61e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GLP1R—type 2 diabetes mellitus	2.02e-05	8.51e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—HMGA1—type 2 diabetes mellitus	1.97e-05	8.28e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PSMD6—type 2 diabetes mellitus	1.93e-05	8.12e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—SNAP25—type 2 diabetes mellitus	1.93e-05	8.12e-05	CbGpPWpGaD
Clodronate—SLC25A4—Disease—AKT1—type 2 diabetes mellitus	1.91e-05	8.07e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLC2A2—type 2 diabetes mellitus	1.89e-05	7.94e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CYBA—type 2 diabetes mellitus	1.87e-05	7.87e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MTR—type 2 diabetes mellitus	1.85e-05	7.78e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CPT1A—type 2 diabetes mellitus	1.85e-05	7.78e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NAMPT—type 2 diabetes mellitus	1.81e-05	7.63e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CALCA—type 2 diabetes mellitus	1.81e-05	7.61e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.8e-05	7.59e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HBA1—type 2 diabetes mellitus	1.8e-05	7.59e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—LIPC—type 2 diabetes mellitus	1.8e-05	7.59e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GCK—type 2 diabetes mellitus	1.8e-05	7.59e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP11A1—type 2 diabetes mellitus	1.79e-05	7.54e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLC9A1—type 2 diabetes mellitus	1.76e-05	7.4e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—SLC2A1—type 2 diabetes mellitus	1.74e-05	7.35e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CETP—type 2 diabetes mellitus	1.74e-05	7.32e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOS1—type 2 diabetes mellitus	1.72e-05	7.24e-05	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.7e-05	7.18e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—TCF7L2—type 2 diabetes mellitus	1.7e-05	7.16e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—SLC2A4—type 2 diabetes mellitus	1.67e-05	7.04e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.62e-05	6.82e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SNAP25—type 2 diabetes mellitus	1.61e-05	6.8e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PSMD6—type 2 diabetes mellitus	1.61e-05	6.8e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SREBF1—type 2 diabetes mellitus	1.61e-05	6.8e-05	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—AKT1—type 2 diabetes mellitus	1.6e-05	6.76e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CTGF—type 2 diabetes mellitus	1.58e-05	6.68e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HMGCR—type 2 diabetes mellitus	1.57e-05	6.62e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.55e-05	6.53e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ADRA2A—type 2 diabetes mellitus	1.54e-05	6.48e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	1.48e-05	6.22e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	1.46e-05	6.15e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	1.46e-05	6.15e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	1.45e-05	6.13e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	1.42e-05	6e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	1.41e-05	5.94e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.4e-05	5.9e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	1.4e-05	5.9e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—APOB—type 2 diabetes mellitus	1.37e-05	5.79e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—LPL—type 2 diabetes mellitus	1.31e-05	5.53e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	1.28e-05	5.41e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	1.23e-05	5.19e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CCR5—type 2 diabetes mellitus	1.21e-05	5.09e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.21e-05	5.08e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	1.21e-05	5.08e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	1.2e-05	5.06e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	1.18e-05	4.99e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	1.18e-05	4.98e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	1.15e-05	4.85e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	1.13e-05	4.75e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—IRS2—type 2 diabetes mellitus	1.12e-05	4.73e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	1.12e-05	4.72e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CALM1—type 2 diabetes mellitus	1.1e-05	4.65e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—APOE—type 2 diabetes mellitus	1.1e-05	4.63e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	1.1e-05	4.63e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—APOA1—type 2 diabetes mellitus	1.09e-05	4.58e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	1.08e-05	4.53e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	1.07e-05	4.52e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	1.04e-05	4.4e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.03e-05	4.34e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOS2—type 2 diabetes mellitus	1.02e-05	4.32e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	9.89e-06	4.17e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—IRS1—type 2 diabetes mellitus	9.81e-06	4.13e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	9.7e-06	4.09e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	9.4e-06	3.96e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—INS—type 2 diabetes mellitus	9.39e-06	3.96e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	9.24e-06	3.89e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	9.21e-06	3.88e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	9.1e-06	3.84e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—AKT2—type 2 diabetes mellitus	9.08e-06	3.83e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	8.63e-06	3.64e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	8.24e-06	3.47e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOS3—type 2 diabetes mellitus	8.24e-06	3.47e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	8.02e-06	3.38e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—INS—type 2 diabetes mellitus	7.87e-06	3.31e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	7.21e-06	3.04e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	6.9e-06	2.91e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	6.9e-06	2.91e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—SRC—type 2 diabetes mellitus	6.09e-06	2.57e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	5.45e-06	2.3e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—EGFR—type 2 diabetes mellitus	5.34e-06	2.25e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—IL6—type 2 diabetes mellitus	4.1e-06	1.73e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—AKT1—type 2 diabetes mellitus	3.79e-06	1.6e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	3.17e-06	1.34e-05	CbGpPWpGaD
